← Back to patent-cliff list
VB-15010
Tier C — Watch / tradeVB-15010
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：PARP1
Indications (approved)：Bile duct cancer, Colorectal cancer, Ovarian cancer, Prostate cancer, Breast cancer, Solid tumour, Pancreatic cancer
Regional status
US
-
EU
-
China
Phase II
2024-10-30
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of VB-15010?
Approved indications include: Bile duct cancer, Colorectal cancer, Ovarian cancer, Prostate cancer, Breast cancer, Solid tumour, Pancreatic cancer.
When does the VB-15010 patent expire?
No public expiry year is available for VB-15010 yet; this page updates once verified.
How do I get a quote for VB-15010 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-01